stoxline Quote Chart Rank Option Currency Glossary
  
Marpai, Inc. (MRAI)
1.05  0.099 (10.4%)    04-17 14:12
Open: 1.04
High: 1.06
Volume: 3,100
  
Pre. Close: 0.9511
Low: 1.04
Market Cap: 15(M)
Technical analysis
2025-04-17 4:50:52 PM
Short term     
Mid term     
Targets 6-month :  1.47 1-year :  1.71
Resists First :  1.25 Second :  1.47
Pivot price 0.98
Supports First :  0.98 Second :  0.81
MAs MA(5) :  0.97 MA(20) :  1
MA(100) :  1.03 MA(250) :  0.98
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  51.1 D(3) :  41.6
RSI RSI(14): 54.5
52-week High :  2.67 Low :  0.4
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MRAI ] has closed below upper band by 30.2%. Bollinger Bands are 10.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.06 - 1.07 1.07 - 1.07
Low: 1.03 - 1.03 1.03 - 1.04
Close: 1.04 - 1.05 1.05 - 1.06
Company Description

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.

Headline News

Tue, 15 Apr 2025
Marpai, Inc. to Present at the Planet MicroCap Showcase Las Vegas - The Malaysian Reserve

Tue, 15 Apr 2025
Exclusive: Marpai Leadership Team Reveals Growth Vision at Major Investor Conference - Stock Titan

Sat, 29 Mar 2025
Marpai, Inc. (NASDAQ:MRAI) Q4 2024 Earnings Call Transcript - Insider Monkey

Wed, 26 Mar 2025
MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS - Yahoo Finance

Thu, 20 Mar 2025
MARPAI TO HOST WEBCAST ON MARCH 27, 2025 TO DISCUSS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS - Yahoo

Thu, 20 Mar 2025
Marpai Financial Results: Healthcare Tech Leader Takes on $22B TPA Market - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
OTC
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 14 (M)
Shares Float 2 (M)
Held by Insiders 70.6 (%)
Held by Institutions 0 (%)
Shares Short 12 (K)
Shares Short P.Month 117 (K)
Stock Financials
EPS -2.93
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.33
Profit Margin -92.8 %
Operating Margin -65.2 %
Return on Assets (ttm) -37.3 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -28.4 %
Gross Profit (p.s.) 0
Sales Per Share 2.32
EBITDA (p.s.) -1.34
Qtrly Earnings Growth 0 %
Operating Cash Flow -14 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -0.36
PEG Ratio 0
Price to Book value -0.46
Price to Sales 0.45
Price to Cash Flow -1.06
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android